REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 26 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,237,000 | -89.9% | 1,146,000 | -92.4% | 0.11% | -90.4% |
| Q2 2022 | $12,253,000 | -19.7% | 15,058,000 | -7.3% | 1.16% | -13.5% |
| Q1 2022 | $15,254,000 | -16.8% | 16,238,000 | +2.1% | 1.34% | -16.1% |
| Q3 2021 | $18,336,000 | -1.2% | 15,910,000 | 0.0% | 1.60% | -3.7% |
| Q2 2021 | $18,551,000 | +5.7% | 15,910,000 | +1.7% | 1.66% | -19.7% |
| Q1 2021 | $17,558,000 | – | 15,650,000 | – | 2.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 20,087 | $23,535,000 | 2.18% |
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,551,000 | 1.66% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,231,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,918,000 | $5,752,000 | 0.17% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,500,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,500,000 | $14,646,000 | 0.03% |
| Citadel Advisors | 104,329,000 | $122,081,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 20,000,000 | $23,433,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,416,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $56,240,000 | 0.02% |